US 11357870
Codon optimized REP1 genes and uses thereof
granted A61KA61K48/005A61K48/0058
Quick answer
US patent 11357870 (Codon optimized REP1 genes and uses thereof) held by 4D MOLECULAR THERAPEUTICS INC. expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- 4D MOLECULAR THERAPEUTICS INC.
- Grant date
- Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K48/005, A61K48/0058, A61K48/0066, A61K48/0075